Breast Cancer - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Last Posted: Jul-08-2019 10:55:06

What's New

Last Posted: Jul 03, 2019

---

• BRCA germline mutation test for all woman with ovarian cancer?  
  Paradiso A V et al. BMC cancer 2019 Jun 19(1) 641
• Clinical Translatability of "Identified" Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update.  
  Grimaldi Anna Maria et al. Cancers 2019 Jun 11(7)
• Differential Profile of BRCA1 vs. BRCA2 Mutated Families: A Characterization of the Main Differences and Similarities in Patients.  
  Fernandes Gabriela Carvalho et al. Asian Pacific journal of cancer prevention : APJCP 2019 20(6) 1655-1660
• Genetic testing and insurance in Australia.  
  Otlowski Margaret et al. Australian journal of general practice 2019 Mar 48(3) 96-99
• Genetic Testing for Breast Cancer Susceptibility Should Be Offered before Unilateral Abdominally Based Free Flap Breast Reconstruction.  
  Dayan Erez et al. Plastic and reconstructive surgery 2019 Jul 144(1) 12-20
• HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology.  
  Brain Etienne et al. Journal of geriatric oncology 2019 Jun
• New name for breast-cancer syndrome could help to save lives  
  CC Pritchard, Nature, July 3, 2019
• Rate of BRCA mutation in patients tested under NCCN genetic testing criteria.  
  Beck Anna C et al. American journal of surgery 2019 Jun
• Should All Patients With a Diagnosis of Breast Cancer Undergo Expanded Panel Testing?  
  Copur Mehmet Sitki et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Jun JCO1900064
• Discussion: Genetic Testing for Breast Cancer Susceptibility Should Be Offered before Unilateral Abdominally Based Free Flap Breast Reconstruction.  
  Jensen Jay Arthur et al. Plastic and reconstructive surgery 2019 Jul 144(1) 21-22
• Emerging Role of Genomics and Cell-Free DNA in Breast Cancer.  
  Gerratana Lorenzo et al. Current treatment options in oncology 2019 Jun 20(8) 68
• Biomarker profiling for breast cancer detection: translational research to determine acceptance of a novel breast cancer screening technique.  
  Carcioppolo Nick et al. Health systems (Basingstoke, England) 2019 8(1) 44-51
• BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.  
  Bisgin Atil et al. The breast journal 2019 Jun
• MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.  
  Saadatmand Sepideh et al. The Lancet. Oncology 2019 Jun
• Revisiting Non-BRCA1/2 Familial Whole Exome Sequencing Datasets Implicates NCK1 as a Cancer Gene.  
  Yin Jie et al. Frontiers in genetics 2019 10527